Inhibition of Myosin Phosphatase by Upregulated Rho-Kinase Plays a Key Role for Coronary Artery Spasm in a Porcine Model With Interleukin-1β

Background—We recently demonstrated that the Rho-kinase–mediated pathway plays an important role for coronary artery spasm in our porcine model with interleukin-1β (IL-1β). In this study, we examined whether or not Rho-kinase is upregulated at the spastic site and if so, how it induces vascular smooth muscle hypercontraction. Methods and Results—Segments of the left porcine coronary artery were chronically treated from the adventitia with IL-1β–bound microbeads. Two weeks after the operation, as reported previously, intracoronary serotonin repeatedly induced coronary hypercontractions at the IL-1β–treated site both in vivo and in vitro, which were markedly inhibited by Y-27632, one of the specific inhibitors of Rho-kinase. Reverse transcription–polymerase chain reaction analysis demonstrated that the expression of Rho-kinase mRNA was significantly increased in the spastic compared with the control segment. Western blot analysis showed that during the serotonin-induced contractions, the extent of phosphory...

[1]  V. Fuster,et al.  Coronary artery disease: pathogenesis and acute coronary syndromes. , 2001, The Mount Sinai journal of medicine, New York.

[2]  A. Takeshita,et al.  Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. , 1999, Cardiovascular research.

[3]  Toshio Kitazawa,et al.  Possible involvement of the novel CPI‐17 protein in protein kinase C signal transduction of rabbit arterial smooth muscle , 1998, Journal of Physiology.

[4]  A. Takeshita,et al.  Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1beta. , 1997, Circulation.

[5]  YoshikazuYonemitsu,et al.  Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1β in Pigs in Vivo , 1997 .

[6]  A. Takeshita,et al.  Vasculoprotective Role of Inducible Nitric Oxide Synthase at Inflammatory Coronary Lesions Induced by Chronic Treatment With Interleukin-1β in Pigs in Vivo , 1997 .

[7]  Shuh Narumiya,et al.  Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension , 1997, Nature.

[8]  K. Kaibuchi,et al.  Rho-associated Kinase Directly Induces Smooth Muscle Contraction through Myosin Light Chain Phosphorylation* , 1997, The Journal of Biological Chemistry.

[9]  J. Nishimura,et al.  Expression of rho A and rho kinase mRNAs in porcine vascular smooth muscle. , 1996, Biochemical and biophysical research communications.

[10]  Yoshiharu Matsuura,et al.  Phosphorylation and Activation of Myosin by Rho-associated Kinase (Rho-kinase)* , 1996, The Journal of Biological Chemistry.

[11]  A. Takeshita,et al.  Coronary Artery Spasm Does Not Depend on the Intracellular Calcium Store but Is Substantially Mediated by the Protein Kinase C–Mediated Pathway in a Swine Model With Interleukin-1β In Vivo , 1996 .

[12]  Kozo Kaibuchi,et al.  Regulation of Myosin Phosphatase by Rho and Rho-Associated Kinase (Rho-Kinase) , 1996, Science.

[13]  A. Hall,et al.  Role of guanine nucleotide-binding proteins--ras-family or trimeric proteins or both--in Ca2+ sensitization of smooth muscle. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[14]  A. Takeshita,et al.  Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. , 1996, The Journal of clinical investigation.

[15]  T. Ohmori,et al.  A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. , 1995, Journal of biochemistry.

[16]  A. Takeshita,et al.  Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo. , 1995, The Journal of clinical investigation.

[17]  K. Kurokawa,et al.  Involvement of rho in GTPγS‐induced enhancement of phosphorylation of 20 kDa myosin light chain in vascular smooth muscle cells: inhibition of phosphatase activity , 1995, FEBS letters.

[18]  T. Tanaka,et al.  Characterization of the myosin-binding subunit of smooth muscle myosin phosphatase. , 1994, The Journal of biological chemistry.

[19]  Andrew P. Somlyo,et al.  Signal transduction and regulation in smooth muscle , 1994, Nature.

[20]  A. Takeshita,et al.  Role of protein kinase C-mediated pathway in the pathogenesis of coronary artery spasm in a swine model. , 1994, Circulation.

[21]  A. Suzuki,et al.  Effects of calyculin A on tension and myosin phosphorylation in skinned smooth muscle of the rabbit mesenteric artery , 1993, British journal of pharmacology.

[22]  P. Cohen,et al.  The control of protein phosphatase-1 by targetting subunits. The major myosin phosphatase in avian smooth muscle is a novel form of protein phosphatase-1. , 1992, European journal of biochemistry.

[23]  P. Cohen,et al.  Arachidonic acid inhibits myosin light chain phosphatase and sensitizes smooth muscle to calcium. , 1992, The Journal of biological chemistry.

[24]  T. Sasaki,et al.  Involvement of rho p21 in the GTP-enhanced calcium ion sensitivity of smooth muscle contraction. , 1992, The Journal of biological chemistry.

[25]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[26]  J. Altiere,et al.  Clin-Alert , 1991 .

[27]  D. Hartshorne,et al.  Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. , 1989, Biochemical and biophysical research communications.

[28]  H. Shimokawa,et al.  Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin. , 1987, Circulation research.

[29]  D. Hartshorne,et al.  Phosphorylation of the 20,000-dalton light chain of smooth muscle myosin by the calcium-activated, phospholipid-dependent protein kinase. Phosphorylation sites and effects of phosphorylation. , 1987, The Journal of biological chemistry.

[30]  K. Morgan,et al.  Alterations in cytoplasmic calcium sensitivity during porcine coronary artery contractions as detected by aequorin. , 1987, The Journal of physiology.

[31]  R. Virmani,et al.  Increased adventitial mast cells in a patient with coronary spasm. , 1985, The New England journal of medicine.

[32]  K. Tanaka,et al.  Coronary artery spasm induced in miniature swine: angiographic evidence and relation to coronary atherosclerosis. , 1985, American heart journal.

[33]  M. Nobuyoshi,et al.  Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. , 1985, Circulation.

[34]  K. Tanaka,et al.  Coronary artery spasm induced in atherosclerotic miniature swine. , 1983, Science.

[35]  D. Hartshorne.  Biochemical basis for contraction of vascular smooth muscle. , 1980, Chest.

[36]  S. Chierchia,et al.  "Variant" angina: one aspect of a continuous spectrum of vasospastic myocardial ischemia. Pathogenetic mechanisms, estimated incidence and clinical and coronary arteriographic findings in 138 patients. , 1978, The American journal of cardiology.

[37]  勝又 直樹.  Enhanced myosin light chain phosphorylations as a central mechanism for coronary artery spasm in a swine model with interleukin-1β , 2002 .

[38]  J. Stull,et al.  Regulation of smooth muscle contractile elements by second messengers. , 1989, Annual review of physiology.

[39]  P. Vanhoutte,et al.  Spasm of the coronary arteries: causes and consequences (the scientist's viewpoint). , 1985, Mayo Clinic proceedings.